These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5324990)

  • 1. Is Peritrate life-sustaining?
    Med Lett Drugs Ther; 1966 Jan; 8(2):5-7. PubMed ID: 5324990
    [No Abstract]   [Full Text] [Related]  

  • 2. Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate.
    Dagenais GR; Mason RE; Friesinger GC; Wender C; Ross RS
    Johns Hopkins Med J; 1969 Dec; 125(6):301-11. PubMed ID: 4905736
    [No Abstract]   [Full Text] [Related]  

  • 3. [Angina pectoris: clinical estimation of prophylaxis in open units].
    Finnson M; Nyberg G
    Lakartidningen; 1969 Dec; 66(49):5137-45. PubMed ID: 4908066
    [No Abstract]   [Full Text] [Related]  

  • 4. [The drug therapy effect on functional and organic stenocardias].
    Gill E
    Med Klin; 1966 Aug; 61(32):1258-60. PubMed ID: 4870033
    [No Abstract]   [Full Text] [Related]  

  • 5. Timed-release pentaerythritol tetranitrate and placebo in the management of angina pectoris.
    Cole RE; Goldberg RI
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):551-7. PubMed ID: 4965503
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experimentation with a combination of a beta-blocking agent and a nitro derivative in the prevention of anginous crises and in the basic treatment of coronary insufficiency].
    Borroni G
    Clin Ter; 1970 May; 53(3):247-58. PubMed ID: 4393972
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylactic therapy of angina pectoris with organic nitrates: relationship of drug efficacy and clinical experimental design.
    Stipe AA; Fink GB
    J Clin Pharmacol; 1973 Jul; 13(7):244-50. PubMed ID: 4197275
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new 2-phase coronary agent for the treatment of angina pectoris due to coronary disease].
    Gill E
    Med Welt; 1978 Mar; 29(10):408-11. PubMed ID: 416316
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.
    Aubert A; Nyberg G; Slaastad R; Tjeldflaat L
    Br Med J; 1970 Jan; 1(5690):203-6. PubMed ID: 4391702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of Peritrate in acute coronary insufficiency].
    Tricot R; Valère P; Castillo A
    Therapeutique; 1971 Nov; 47(9):777-8. PubMed ID: 4947933
    [No Abstract]   [Full Text] [Related]  

  • 11. Antianginal effects of pentaerythritol tetranitrate.
    Arce-Gomez E; Aspe y Rosas J; Alcocer Diaz Barreiro L; Diaz Barreiro AL
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2487-91. PubMed ID: 6775303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical considerations on the use of an antispastic-antivagal drug association in the cholecysto-coronary syndrome].
    Cristiano P; Panzitta S; Cuiuli V; Petronio A; Giraldi A
    Minerva Gastroenterol; 1973; 19(4):259-69. PubMed ID: 4592525
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary vasodilators.
    J Kans Med Soc; 1968 Apr; 69(4):180-1. PubMed ID: 4967709
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nitro-sandolanid in angina pectoris].
    Stieglitz T
    Med Welt; 1973 Apr; 24(16):655-6. PubMed ID: 4756332
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of angina pectoris with Dilcoran 80].
    Strickler W
    Landarzt; 1967 Oct; 43(30):1485-9. PubMed ID: 5609195
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of pentaerythritol tetranitrate (peritrate) in treatment of angina pectoris.
    TALLEY RW; BEARD OW; DOHERTY JF
    Am Heart J; 1952 Dec; 44(6):866-71. PubMed ID: 12996435
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
    Gatti A; Scotti G
    Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
    [No Abstract]   [Full Text] [Related]  

  • 19. Exercise performance and electrocardiographic changes as indices of effect of long-acting nitrates in angina pectoris.
    Abrahamsen AM; Kiil F
    Br Med J; 1966 Feb; 1(5485):456-8. PubMed ID: 5902683
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical study comparing the effect of small doses of heparin with the effects of carbocromen and pentaerythrityl tetranitrate in angina pectoris. Some questions of the therapeutical mechanism of heparin.
    Goldberg GA; Suriadnova BA; Stepanov MA; Kochanko EP
    Cor Vasa; 1972; 14(2):81-95. PubMed ID: 5050956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.